- Home
- NTRB vs ICMB Comparison
NTRB vs ICMB Comparison
Compare NTRB & ICMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTRB
- ICMB
- Stock Information
- Founded
- NTRB 2016
- ICMB 2012
- Country
- NTRB United States
- ICMB United States
- Employees
- NTRB N/A
- ICMB N/A
- Industry
- NTRB Industrial Specialties
- ICMB Finance: Consumer Services
- Sector
- NTRB Health Care
- ICMB Finance
- Exchange
- NTRB Nasdaq
- ICMB Nasdaq
- Market Cap
- NTRB 77.9M
- ICMB 48.0M
- IPO Year
- NTRB N/A
- ICMB N/A
- Fundamental
- Price
- NTRB $7.91
- ICMB $3.24
- Analyst Decision
- NTRB
- ICMB
- Analyst Count
- NTRB 0
- ICMB 0
- Target Price
- NTRB N/A
- ICMB N/A
- AVG Volume (30 Days)
- NTRB 51.9K
- ICMB 30.8K
- Earning Date
- NTRB 12-11-2024
- ICMB 11-11-2024
- Dividend Yield
- NTRB N/A
- ICMB 14.84%
- EPS Growth
- NTRB N/A
- ICMB N/A
- EPS
- NTRB N/A
- ICMB N/A
- Revenue
- NTRB $1,803,816.00
- ICMB $23,878,302.00
- Revenue This Year
- NTRB N/A
- ICMB $10.32
- Revenue Next Year
- NTRB N/A
- ICMB N/A
- P/E Ratio
- NTRB N/A
- ICMB N/A
- Revenue Growth
- NTRB N/A
- ICMB N/A
- 52 Week Low
- NTRB $1.53
- ICMB $2.98
- 52 Week High
- NTRB $9.60
- ICMB $3.97
- Technical
- Relative Strength Index (RSI)
- NTRB 73.07
- ICMB 60.03
- Support Level
- NTRB $6.17
- ICMB $3.14
- Resistance Level
- NTRB $7.74
- ICMB $3.23
- Average True Range (ATR)
- NTRB 0.58
- ICMB 0.08
- MACD
- NTRB 0.16
- ICMB 0.01
- Stochastic Oscillator
- NTRB 89.11
- ICMB 84.87
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's lead product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.
About ICMB Investcorp Credit Management BDC Inc.
Investcorp Credit Management BDC Inc is an externally managed, non-diversified closed-end management investment firm that has elected to be regulated as a business development company (BDC). Its investment objective is to maximize total return to stockholders in the form of current income and capital appreciation by investing in debt and related equity of privately held lower middle-market companies. The company principally invests in the debt of middle-market companies, which it defines as those companies that have an enterprise value.